Skip to main content

OLMESARTAN MEDOXOMIL

NDC 31722-854 · Camber Pharmaceuticals, Inc.

Generic nameOLMESARTAN MEDOXOMIL
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)OLMESARTAN MEDOXOMIL
Strength40 mg/1
Pharmacologic classAngiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]
Marketing categoryANDA

Packages

31722-854-30 — 30 TABLET, FILM COATED in 1 BOTTLE (31722-854-30)

31722-854-90 — 90 TABLET, FILM COATED in 1 BOTTLE (31722-854-90)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

27241-083 — Amlodipine besylate and Olmesartan medoxomil, 27241-084 — Amlodipine besylate and Olmesartan medoxomil, 27241-085 — Amlodipine besylate and Olmesartan medoxomil, 27241-086 — Amlodipine besylate and Olmesartan medoxomil, 31722-445 — Amlodipine and Olmesartan Medoxomil, 31722-446 — Aamlodipine and Olmesartan Medoxomil, 31722-447 — Amlodipine and Olmesartan Medoxomil, 31722-448 — Amlodipine and Olmesartan Medoxomil, 31722-852 — OLMESARTAN MEDOXOMIL, 31722-853 — OLMESARTAN MEDOXOMIL, 31722-886 — Olmesartan medoxomil and hydrochlorothiazide, 31722-887 — Olmesartan medoxomil and hydrochlorothiazide, 31722-888 — Olmesartan medoxomil and hydrochlorothiazide, 31722-892 — Olmesartan medoxomil, amlodipine and hydrochlorothiazide, 31722-893 — Olmesartan medoxomil, amlodipine and hydrochlorothiazide, 31722-894 — Olmesartan medoxomil, amlodipine and hydrochlorothiazide, 31722-895 — Olmesartan medoxomil, amlodipine and hydrochlorothiazide, 31722-896 — Olmesartan medoxomil, amlodipine and hydrochlorothiazide, 33342-173 — OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE, 33342-174 — OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE, +281 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels